iAnthus Capital Holdings Inc. (C:IAN*CA)

Business Focus: Retail - Drugs without Grocery

Sector:  Consumer Non-Cyclicals Industry:  Drug Retailers
See Regulatory Filings on SEDAR
Company Contact
Address: 1075 Georgia St W Suite 1980
Tel: N/A
Website: https://www.ianthuscapital.com
IR: See website
Key People
Randy Maslow
President, Interim Chief Executive Officer, Director
Julius John Kalcevich
Chief Financial Officer, Corporate Secretary, Director
Pat Tiernan
Chief Operating Officer
John Henderson
Senior Vice President - Eastern Operations
Todd Karnig
Senior Vice President - Western Operations
Neil Calvesbert
Chief Marketing Officer
Ray Chevalier
Vice President - Infrastructure
Elizabeth M. Stavola
Chief Strategy Officer and Director
Richard J. Boxer
Chief Medical Officer
Business Overview
iAnthus Capital Holdings Inc, formerly Genarca Holdings Ltd., is a Canada-based company which provides financing and related management and advisory services to operators engaged in the cultivation, manufacturing and dispensing of cannabis in states throughout the United States. The Company supports a portfolio of cannabis industry investments for its shareholders, including direct equity investments in for-profit license holders and lending facilities coupled with management services to not-for-profit license holders. The Company has invested in finance and management partnerships in approximately four states, comprising over eight licenses, approximately nine dispensaries and over four cultivation facilities. The Company provides an investment opportunity in licensed operations across various United States cannabis markets. The Company's subsidiary is iAnthus Capital Management, LLC.
Financial Overview
For the nine months ended 30 September 2019, iAnthus Capital Holdings Inc revenues increased from $1.4M to $51.2M. Net loss decreased 7% to $42.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Change in fair value of derivative liabi increase from $9.2M (expense) to $36.2M (income), Accretion expense decrease of 48% to $8M (expense).
Reporting Currency: U.S. Dollars
Enterprise value: $74.06M as of Sep 30, 2019
Annual revenue (TTM): $73.72M as of Sep 30, 2019
EBITDA (TTM): -$74.87M as of Sep 30, 2019
Net annual income (TTM): -$79.85M as of Sep 30, 2019
Free cash flow (TTM): -$121.96M as of Sep 30, 2019
Net Debt Last Fiscal Year: $140.85M as of Sep 30, 2019
Shares outstanding: 171,718,192 as of Apr 6, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization